OSCOTECInc. Logo

OSCOTECInc.

Clinical-stage drug discovery for immunology, oncology, and neurodegenerative disorders.

039200 | KO

Overview

Corporate Details

ISIN(s):
KR7039200001
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 대왕판교로 700 A-901(삼평동,코리아바이오파크), 성남시

Description

Oscotec Inc. is a clinical-stage drug discovery and development company focused on translating scientific research into innovative medicines for clinically unmet needs. The company's development pipeline targets various diseases, with a primary focus on immunology, oncology, and neurodegenerative disorders. Key therapeutic areas include rheumatoid arthritis, immune thrombocytopenia, non-small cell lung cancer, acute myeloid leukemia, and Alzheimer's disease. Oscotec specializes in developing novel kinase inhibitors, such as Spleen Tyrosine Kinase (SYK) inhibitors, to address these conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-10-21 00:00
기업설명회(IR)개최
Korean 6.8 KB
2024-09-11 00:00
투자판단관련주요경영사항 (유한양행의 얀센바이오테크 기술이전 마일스톤 분배)
Korean 8.1 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.2 MB
2024-06-28 00:00
주식등의대량보유상황보고서(일반)
Korean 88.0 KB
2024-05-14 00:00
분기보고서 (2024.03)
Korean 1.1 MB
2024-04-12 00:00
기업설명회(IR)개최
Korean 6.8 KB
2024-03-27 00:00
정기주주총회결과
Korean 18.7 KB
2024-03-26 00:00
소송등의판결ㆍ결정 (검사인 선임)
Korean 5.7 KB
2024-03-25 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 8.1 KB
2024-03-18 00:00
감사보고서제출
Korean 25.2 KB
2024-03-18 00:00
사업보고서 (2023.12)
Korean 485.4 KB
2024-03-14 00:00
[기재정정]의결권대리행사권유참고서류
Korean 45.4 KB
2024-03-13 00:00
의결권대리행사권유참고서류
Korean 43.3 KB
2024-03-11 00:00
주주총회소집공고
Korean 953.7 KB
2024-03-11 00:00
의결권대리행사권유참고서류
Korean 947.0 KB

Automate Your Workflow. Get a real-time feed of all OSCOTECInc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OSCOTECInc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OSCOTECInc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.